Assembly-formed bioorthogonal chimeric artificial receptors enable high-contrast fluorescence imaging of tumors
Science Advances · 07.08.2026 · 12 (32)
DOI: 10.1126/sciadv.aed9403 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Advances, erschienen am 07.08.2026. Verfasst von Jianli Zuo und 10 weiteren Autor:innen. Beteiligte Einrichtung: Chongqing Research Center for Pharmaceutical Engineering, College of Pharmacy, Chongqing Medical University, Chongqing, China. Hauptthemen laut MEDLINE: Urinary Bladder Neoplasms, Optical Imaging, Receptors, Artificial. Die Arbeit nennt 58 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: National Natural Science Foundation of China, National Key Research and Development Program of China, Chongqing Natural Science Foundation.
Abstract (Originalsprache)
Conventional receptor-targeted fluorescent probes have shown promise in tumor imaging, yet achieving a high tumor-to-normal (T/N) tissue ratio in vivo remains challenging due to limited biomarker density on tumor cell membranes. Here, we present an in situ assembly strategy of bioorthogonal-functionalized chimeric artificial receptors (BCARs) that locally constructs BCARs on tumor surfaces, which amplify fluorescence signals and enable high-contrast imaging. Rapid, selective membrane engineering under physiological conditions increases effective receptor density, enhancing fluorophore binding and tumor visualization. Mechanistic studies reveal that BCARs exhibit exceptional membrane retention and spatial precision, sustaining signal amplification in heterogeneous tumor microenvironments. In air-pouch and orthotopic bladder cancer models, BCARs notably improve the T/N imaging ratio and tumor boundary delineation. Translational validation with surgical specimens from 14 patients with bladder cancer confirms clinical feasibility. This work establishes a versatile platform for on-site receptor reprogramming and signal amplification, offering a powerful tool for high-contrast tumor margin detection.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Chongqing Research Center for Pharmaceutical Engineering, College of Pharmacy, Chongqing Medical University, Chongqing, China.
- Department of Urology of Jiangbei Campus, The First Affiliated Hospital of Army Medical University, Chongqing, China.
- Basic Medicine Research and Innovation Center for Novel Target and Therapeutic Intervention, Ministry of Education, College of Pharmacy, Chongqing Medical University, Chongqing, China.
- Department of Respiratory and Critical Care Medicine, Department of Tuberculosis, the First Affiliated Hospital of Chongqing Medical University, Chongqing, China.
ORCID-Profile: Jianli Zuo, Yuxi Tan, Zhaode Mu, Yongjun Dang, Lijuan Bai, Hongwen Liang
Förderung
- National Natural Science Foundation of China
- National Key Research and Development Program of China
- Chongqing Natural Science Foundation
- Scientific and technological research program of Chongqing municipal education commission
- Open Competition for Key Research Projects
- Technological Research Program of Chongqing Municipal Education Commission
- BAYU Scholar Program Young Scholar
- The Young and Middle aged Medical High end Talent Project of Chongqing
Zitieren
APA
Zuo, J., Tan, Y., Mu, Z., Dong, Y., Wu, Y., Li, Y., Yuan, Y., Wang, X., Dang, Y., Bai, L., & Liang, H. (2026). Assembly-formed bioorthogonal chimeric artificial receptors enable high-contrast fluorescence imaging of tumors. Science Advances, 12(32). https://doi.org/10.1126/sciadv.aed9403
Vancouver
Zuo J, Tan Y, Mu Z, Dong Y, Wu Y, Li Y, et al. Assembly-formed bioorthogonal chimeric artificial receptors enable high-contrast fluorescence imaging of tumors. Science Advances. 2026;12(32). doi:10.1126/sciadv.aed9403
BibTeX
@article{Zuo2026,
author = {Zuo, Jianli and Tan, Yuxi and Mu, Zhaode and Dong, Yuhan and Wu, Yijie and Li, Yanzhi and Yuan, Yonghua and Wang, Xiaobo and Dang, Yongjun and Bai, Lijuan and Liang, Hongwen},
title = {Assembly-formed bioorthogonal chimeric artificial receptors enable high-contrast fluorescence imaging of tumors},
journal = {Science Advances},
year = {2026},
volume = {12},
number = {32},
doi = {10.1126/sciadv.aed9403}
}
EUVIMED